Tinker, Tailor, Soldier, Biotech Spy?

On a dreary day last December, two men entered a hotel room in the Boston suburb of Framingham, Mass. One wore the expensive clothes of a prosperous businessman, the other had the tweedy attire of a research scientist. Inside the cooler they carried was a tiny frozen cluster of genetically altered hamster ovary cells, capable of producing the blockbuster drug known as erythropoietin, or EPO. Waiting to collect the cells was an FBI undercover agent posing as a buyer for Russia's KGB.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.